Seasoned pharmaceutical professional with eighteen years of experience in the industry. Having started as a CRA in oncology, immunology, virology and rheumatology; I worked into management of CRAs in AbbVie’s hepatitis C research leading to successful approval of Mavyret. I Led AbbVie’s efforts in Gastro areas of Crohn’s Disease and Ulcerative Colitis as the Operations Director bringing Skyrizi and Rinvoq to Market.I received the AbbVie President's Award in 2021 for leading the efforts to establish Covid 19 guidelines, allowing the business to continue without interruption. With these efforts, we were able to successfully navigate FDA submission of risankinzumab for Crohn's Disease. I was one of two individuals that presented to the FDA inspectors during the approval process.In 2024, I led the team through successful completion of the highest profile study for risankinzumab to accomplish our marketing strategies for Skyrizi.